RECRUITING

Blue Light Cystoscopy With Cysview® Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Official Title

Blue Light Cystoscopy With Cysview® Registry

Quick Facts

Study Start:2014-04
Study Completion:2028-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02660645

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult \>18 years old
  2. * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
  1. * Porphyria
  2. * Gross hematuria
  3. * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

Contacts and Locations

Study Contact

Chad McKee, PhD
CONTACT
(919) 780-0417
chad.mckee@photocure.com

Principal Investigator

Siamak Daneshmand, MD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

The University of Alabama at Birmingham
Birmingham, Alabama, 35294
United States
Mayo Clinic
Phoenix, Arizona, 85054
United States
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States
University of California Los Angeles
Los Angeles, California, 90095
United States
VA Palo Alto Health Care System
Palo Alto, California, 94304
United States
University of California, San Francisco
San Francisco, California, 94143
United States
Sibley Memorial Hospital
Washington, District of Columbia, 20016
United States
Emory University School of Medicine
Atlanta, Georgia, 30097
United States
Northwestern University
Chicago, Illinois, 60611
United States
Northshore University Health System
Evanston, Illinois, 60201
United States
Indiana University School of Medicine
Indianapolis, Indiana, 46202
United States
University of Kansas Medical Center
Kansas City, Kansas, 66160
United States
Johns Hopkins Medicine
Baltimore, Maryland, 21224
United States
University of Minnesota
Minneapolis, Minnesota, 55455
United States
NYU Langone's Perlmutter Cancer Center
New York, New York, 10016
United States
Stony Brook Urology
Stony Brook, New York, 11794
United States
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210
United States
Ohio State University
Columbus, Ohio, 43210
United States
Lexington Medical Center
West Columbia, South Carolina, 29169
United States
UT Southwestern
Dallas, Texas, 75390
United States
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030
United States
University of Washington Medicine
Seattle, Washington, 98195
United States
Charleston Area Medical Center
Charleston, West Virginia, 25301
United States

Collaborators and Investigators

Sponsor: Photocure

  • Siamak Daneshmand, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-04
Study Completion Date2028-12

Study Record Updates

Study Start Date2014-04
Study Completion Date2028-12

Terms related to this study

Keywords Provided by Researchers

  • Cysview
  • Hexaminolevulinate
  • Hexvix
  • NMIBC
  • BLCC
  • Blue Light Cystoscopy with Cysview
  • Cystoscopy
  • TURBT
  • TUR
  • Fluorescent cystoscopy
  • Non-muscle invasive bladder cancer (NMIBC)
  • Transurethral resection (TUR)

Additional Relevant MeSH Terms

  • Bladder Cancer